Ameridose LLC, the sister drug company of the Framingham specialty pharmacy that is at the root of a national meningitis outbreak, will now be shut down until at least the end of the year, under an agreement reached Friday with state regulators. To aid hospitals grappling with drug shortages in Massachusetts, state regulators will propose emergency regulations next week that would allow hospital pharmacies to safely share compounded drugs with other hospitals.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help